Home Working Groups Drug Discovery & Pharmacology

Tue,21Oct2014

Drug Discovery & Pharmacology

Working Group 4: Evaluation of gasotransmitter-modifying agents in animal models of disease

Working Group Leader: Peter Brouckaert (Gent, Belgium)

  • Andreadou Ioanna, (Athens, Greece)
  • Baxter, Gary (Cardiff, UK)
  • Brouckaert, Peter (Gent, Belgium)
  • Cirino, Giuseppe (Naples, Italy)
  • Djurić, Dragan (Belgrade, Serbia)
  • Ferdinandy, Peter (Szeged, Hungary)
  • Glynos Konstantinos (Athens, Greece)
  • Hobbs, Adrian (London, UK)
  • Jozkowicz, Alicja (Krakow, Poland)
  • Lefebvre, Romain (Gent, Belgium)
  • Levy, Finn Olav (Oslo, Norway)
  • Mayer, Bernd (Gratz, Austria)
  • Morbidelli, Lucia (Siena, Italy)
  • Pechanova, Olga (Bratislava, Slovakia)
  • Sanchez-Ferrer, Carlos-Felix (Madrid, Spain)
  • Schatzschneider, Ulrich (Würzburg, Germany)
  • Schmidt, Harald (Maastricht, Netherlands)
  • Yetik, Gunay (Izmir, Turkey)

ESF

COST

POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.